Buschman, Brendon

Insider profile

Performance

Overall performance
1.6

Performance over holding periods
1.6
30 days 90 days 120 days
Average return -18% 8.2% 15.1%
Success rate 20% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Buschman, Brendon's trades of Medexus Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
367.22
Quantity 44,263 +32.3%
Value CA$3,034,739
Transaction date
Purchase
Price
292.08
Quantity 86,376 -20.9%
Value CA$1,111,919
Transaction date
Purchase
Price
164.83
Quantity 18,517 +32.1%
Value CA$2,570,773
Transaction date
Purchase
Price
2.45
Quantity 3,600 +5.9%
Value CA$8,806
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-10 2025-02-10 B Purchase
44,263 +32.3%
367.22
CA$3,034,739
44,263 +32.3% 367.22 CA$3,034,739
2025-02-10 2025-02-07 B Purchase
86,376 -20.9%
292.08
CA$1,111,919
86,376 -20.9% 292.08 CA$1,111,919
2024-08-27 2024-08-26 B Purchase
18,517 +32.1%
164.83
CA$2,570,773
18,517 +32.1% 164.83 CA$2,570,773
2024-08-27 2024-08-23 B Purchase
3,600 +5.9%
2.45
CA$8,806
3,600 +5.9% 2.45 CA$8,806